As of February 02, 2025, Global Health Limited (Medanta) (MEDANTA.NS) has a market cap of $3.34 billion USD. According to our data, Global Health Limited (Medanta) is ranked No.3321 in global market value.
Year | Market Cap | %Change |
---|---|---|
Feb 02, 2025 | $3.34 B |
-0.06%
|
Dec 31, 2024 | $3.34 B |
12.44%
|
Dec 29, 2023 | $2.97 B |
104.60%
|
Dec 30, 2022 | $1.45 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Johnson & Johnson
JNJ
|
$366.32 B |
-0.013 M
|
USA
|
Pfizer
PFE
|
$150.29 B |
0.001 M
|
USA
|
Merck
MRK
|
$249.98 B |
-0.007 M
|
USA
|
GlaxoSmithKline
GSK
|
$71.96 B |
-0.000 M
|
UK
|
Novartis
NVS
|
$207.51 B |
0.680 B
|
Switzerland
|
Sanofi
SNY
|
$136.24 B |
-0.003 M
|
France
|
AstraZeneca
AZN
|
$219.43 B |
0.002 M
|
UK
|
AbbVie
ABBV
|
$324.98 B |
0.004 M
|
USA
|
Bristol-Myers Squibb
BMY
|
$119.56 B |
-0.003 M
|
USA
|
Eli Lilly
LLY
|
$729.42 B |
-0.023 M
|
USA
|
Amgen
AMGN
|
$153.42 B |
0.002 M
|
USA
|
Gilead Sciences
GILD
|
$121.14 B |
0.003 M
|
USA
|
Teva Pharmaceutical Industries
TEVA
|
$20.16 B |
68.794 M
|
Israel
|
Market Cap | = | MEDANTA.NS Stock Price | * | MEDANTA.NS Shares Outstanding |
= | $12.39 | * | 0.27 B | |
= | $3.34 B |